Dendritic Cells Require PINK1-Mediated Phosphorylation of BCKDE1α to Promote Fatty Acid Oxidation for Immune Function

by Farhan Basit, I. Jolanda M. de Vries, I. Jolanda M. de Vries
Published 2019-10-01

Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response

by Farhan Basit, Till Mathan, David Sancho, I. Jolanda M. de Vries, I. Jolanda M. de Vries
Published 2018-11-01

Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation

by Simone P. Sittig, I. Jolanda M. de Vries, Gerty Schreibelt
Published 2015-12-01

Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity

by Felix L. Fennemann, I. Jolanda M. de Vries, I. Jolanda M. de Vries, Carl G. Figdor, Carl G. Figdor, Carl G. Figdor, Martijn Verdoes, Martijn Verdoes
Published 2019-04-01

The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer

by Beatriz Subtil, Alessandra Cambi, Daniele V. F. Tauriello, I. Jolanda M. de Vries
Published 2021-10-01

Subsets of CD1c+ DCs: Dendritic Cell Versus Monocyte Lineage

by Lukas Heger, Thomas P. Hofer, Venetia Bigley, I. Jolanda M. de Vries, I. Jolanda M. de Vries, Marc Dalod, Diana Dudziak, Diana Dudziak, Diana Dudziak, Diana Dudziak, Loems Ziegler-Heitbrock
Published 2020-09-01

LDH Isotyping for Checkpoint Inhibitor Response Prediction in Patients with Metastatic Melanoma

by Sandra van Wilpe, Sofie H. Tolmeijer, I. Jolanda M. de Vries, Rutger H. T. Koornstra, Niven Mehra
Published 2021-04-01

Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer

by Johanna Bödder, Tasmin Zahan, Rianne van Slooten, Gerty Schreibelt, I. Jolanda M. de Vries, Georgina Flórez-Grau
Published 2021-02-01

The nature of activatory and tolerogenic dendritic cell-derived signal II

by Ghaith eBakdash, Simone Patricia Sittig, Tjeerd evan Dijk, Carl G. Figdor, I. Jolanda M. de Vries
Published 2013-02-01

Immunotherapy for prostate cancer: Lessons from responses to tumor-associated antigens

by Harm eWestdorp, Harm eWestdorp, Annette E. Skold, Berit A. Snijer, Sebastian eFranik, Sasja F. Mulder, Pierre Paul Major, Ronan eFoley, Winald R. Gerritsen, I. Jolanda M. de Vries, I. Jolanda M. de Vries
Published 2014-05-01

Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG

by Christina Wefers, Christina Wefers, Gerty Schreibelt, Leon F. A. G. Massuger, I. Jolanda M. de Vries, Ruurd Torensma
Published 2018-06-01

STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics

by Nienke de Haas, Coco de Koning, Stefania di Blasio, Georgina Flórez-Grau, I. Jolanda M. de Vries, Stanleyson V. Hato
Published 2019-01-01

Homologous Recombination Repair Deficiency and Implications for Tumor Immunogenicity

by Sandra van Wilpe, Sofie H. Tolmeijer, Rutger H. T. Koornstra, I. Jolanda M. de Vries, Winald R. Gerritsen, Marjolijn Ligtenberg, Niven Mehra
Published 2021-05-01

A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery

by Winald R Gerritsen, Johannes Textor, Niven Mehra, Jeroen H A Creemers, W Joost Lesterhuis, Carl G Figdor, I Jolanda M de Vries
Published 2021-05-01

Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder

by Sandra van Wilpe, Eveline C. F. Gerretsen, Antoine G. van der Heijden, I. Jolanda M. de Vries, Winald R. Gerritsen, Niven Mehra
Published 2020-09-01

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets

by Simone P. Sittig, Ghaith Bakdash, Jorieke Weiden, Annette E. Sköld, Jurjen Tel, Carl G. Figdor, I. Jolanda M. de Vries, Gerty Schreibelt
Published 2016-01-01

PTEN Hamartoma Tumor Syndrome and Immune Dysregulation

by Marc Eissing, Lise Ripken, Gerty Schreibelt, Harm Westdorp, Marjolijn Ligtenberg, Romana Netea-Maier, Mihai G. Netea, I. Jolanda M. de Vries, Nicoline Hoogerbrugge
Published 2019-02-01

An altered gp100 peptide ligand with decreased binding by TCR and CD8alpha dissects T cell cytotoxicity from production of cytokines and activation of NFAT

by Niels eSchaft, Niels eSchaft, miriam eCoccoris, Joost eDrexhage, Christiaan eKnoop, Jolanda M de Vries, Gosse J Adema, Reno eDebets
Published 2013-09-01

High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

by Harm Westdorp, Harm Westdorp, Jeroen H. A. Creemers, Jeroen H. A. Creemers, Inge M. van Oort, Niven Mehra, Niven Mehra, Simone M. Hins-de Bree, Carl G. Figdor, Carl G. Figdor, J. Alfred Witjes, Gerty Schreibelt, I. Jolanda M. de Vries, I. Jolanda M. de Vries, Winald R. Gerritsen, Winald R. Gerritsen, Petronella B. Ottevanger
Published 2020-10-01

Correction: Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential

by Sébastien Anguille, Eva Lion, Jurjen Tel, I. Jolanda M de Vries, Karen Couderé, Phillip D. Fromm, Viggo F. Van Tendeloo, Evelien L. Smits, Zwi N. Berneman
Published 2014-01-01